In situ imaging reveals properties of purinergic signalling in trigeminal sensory ganglia in vitro
- PMID: 28822016
- PMCID: PMC5714839
- DOI: 10.1007/s11302-017-9576-1
In situ imaging reveals properties of purinergic signalling in trigeminal sensory ganglia in vitro
Abstract
Chronic pain is supported by sterile inflammation that induces sensitisation of sensory neurons to ambient stimuli including extracellular ATP acting on purinergic P2X receptors. The development of in vitro methods for drug screening would be useful to investigate cell crosstalk and plasticity mechanisms occurring during neuronal sensitisation and sterile neuroinflammation. Thus, we studied, at single-cell level, membrane pore dilation based on the uptake of a fluorescent probe following sustained ATP-gated P2X receptor function in neurons and non-neuronal cells of trigeminal ganglion cultures from wild-type (WT) and R192Q CaV2.1 knock-in (KI) mice, a model of familial hemiplegic migraine type 1 characterised by neuronal sensitisation and higher release of soluble mediators. In WT cultures, pore responses were mainly evoked by ATP rather than benzoyl-ATP (BzATP) and partly inhibited by the P2X antagonist TNP-ATP. P2X7 receptors were expressed in trigeminal ganglia mainly by non-neuronal cells. In contrast, KI cultures showed higher expression of P2X7 receptors, stronger responses to BzATP, an effect largely prevented by prior administration of CaV2.1 blocker ω-agatoxin IVA, small interfering RNA (siRNA)-based silencing of P2X7 receptors or the P2X7 antagonist A-804598. No cell toxicity was detected with the protocols. Calcitonin gene-related peptide (CGRP), a well-known migraine mediator, potentiated BzATP-evoked membrane permeability in WT as well as R192Q KI cultures, demonstrating its modulatory role on trigeminal sensory ganglia. Our results show an advantageous experimental approach to dissect pharmacological properties potentially relevant to chronic pain and suggest that CGRP is a soluble mediator influencing purinergic P2X pore dilation and regulating inflammatory responses.
Keywords: ATP; CACNA1A; DRG; FHM1; Migraine; P2X3; P2X7; Pain.
Conflict of interest statement
Conflict of interest
Arletta Nowodworska declares that she has no conflict of interest.
Arn M. J. M. van den Maagdenberg declares that he has no conflict of interest.
Andrea Nistri declares that he has no conflict of interest.
Elsa Fabbretti declares that she has no conflict of interest.
Ethical approval
All animal procedures were in accordance with national regulations of animal welfare and approved by the ethics committee of the International School for Advanced Studies (SISSA).
Figures







Similar articles
-
Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 Knock-in mice: implications for basic mechanisms of migraine pain.J Neurosci. 2011 Mar 9;31(10):3638-49. doi: 10.1523/JNEUROSCI.6440-10.2011. J Neurosci. 2011. PMID: 21389219 Free PMC article.
-
Inefficient constitutive inhibition of P2X3 receptors by brain natriuretic peptide system contributes to sensitization of trigeminal sensory neurons in a genetic mouse model of familial hemiplegic migraine.Mol Pain. 2016 May 12;12:1744806916646110. doi: 10.1177/1744806916646110. Print 2016. Mol Pain. 2016. PMID: 27175010 Free PMC article.
-
Effects of LPS on P2X3 receptors of trigeminal sensory neurons and macrophages from mice expressing the R192Q Cacna1a gene mutation of familial hemiplegic migraine-1.Purinergic Signal. 2013 Mar;9(1):7-13. doi: 10.1007/s11302-012-9328-1. Epub 2012 Jul 27. Purinergic Signal. 2013. PMID: 22836594 Free PMC article.
-
Role of ATP in migraine mechanisms: focus on P2X3 receptors.J Headache Pain. 2023 Jan 3;24(1):1. doi: 10.1186/s10194-022-01535-4. J Headache Pain. 2023. PMID: 36597043 Free PMC article. Review.
-
Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF.Mol Neurobiol. 2008 Feb;37(1):83-90. doi: 10.1007/s12035-008-8020-5. Epub 2008 May 6. Mol Neurobiol. 2008. PMID: 18459072 Review.
Cited by
-
Single-cell RNA sequencing reveals distinct transcriptional features of the purinergic signaling in mouse trigeminal ganglion.Front Mol Neurosci. 2022 Oct 13;15:1038539. doi: 10.3389/fnmol.2022.1038539. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36311028 Free PMC article.
-
Microglia P2X4 receptor contributes to central sensitization following recurrent nitroglycerin stimulation.J Neuroinflammation. 2018 Aug 30;15(1):245. doi: 10.1186/s12974-018-1285-3. J Neuroinflammation. 2018. PMID: 30165876 Free PMC article.
-
Involvement of P2X7 receptors in chronic pain disorders.Purinergic Signal. 2022 Mar;18(1):83-92. doi: 10.1007/s11302-021-09796-5. Epub 2021 Nov 20. Purinergic Signal. 2022. PMID: 34799827 Free PMC article. Review.
-
P2X7R-mediated autophagic impairment contributes to central sensitization in a chronic migraine model with recurrent nitroglycerin stimulation in mice.J Neuroinflammation. 2021 Jan 5;18(1):5. doi: 10.1186/s12974-020-02056-0. J Neuroinflammation. 2021. PMID: 33402188 Free PMC article.
-
Migraine and neuroinflammation: the inflammasome perspective.J Headache Pain. 2021 Jun 10;22(1):55. doi: 10.1186/s10194-021-01271-1. J Headache Pain. 2021. PMID: 34112082 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials